ICAR: endoscopic skull-base surgery.

CSF rhinorrhea angiofibroma clival chordoma craniopharyngioma endoscopic endonasal approach endoscopic endonasal skull-base surgery esthesioneuroblastoma evidence-based medicine meningioma nasoseptal flap reconstruction olfactory neuroblastoma pituitary adenoma squamous cell carcinoma

Journal

International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261

Informations de publication

Date de publication:
07 2019
Historique:
received: 26 09 2018
revised: 12 02 2019
accepted: 15 02 2019
entrez: 23 7 2019
pubmed: 23 7 2019
medline: 26 5 2020
Statut: ppublish

Résumé

Endoscopic skull-base surgery (ESBS) is employed in the management of diverse skull-base pathologies. Paralleling the increased utilization of ESBS, the literature in this field has expanded rapidly. However, the rarity of these diseases, the inherent challenges of surgical studies, and the continued learning curve in ESBS have resulted in significant variability in the quality of the literature. To consolidate and critically appraise the available literature, experts in skull-base surgery have produced the International Consensus Statement on Endoscopic Skull-Base Surgery (ICAR:ESBS). Using previously described methodology, topics spanning the breadth of ESBS were identified and assigned a literature review, evidence-based review or evidence-based review with recommendations format. Subsequently, each topic was written and then reviewed by skull-base surgeons in both neurosurgery and otolaryngology. Following this iterative review process, the ICAR:ESBS document was synthesized and reviewed by all authors for consensus. The ICAR:ESBS document addresses the role of ESBS in primary cerebrospinal fluid (CSF) rhinorrhea, intradural tumors, benign skull-base and orbital pathology, sinonasal malignancies, and clival lesions. Additionally, specific challenges in ESBS including endoscopic reconstruction and complication management were evaluated. A critical review of the literature in ESBS demonstrates at least the equivalency of ESBS with alternative approaches in pathologies such as CSF rhinorrhea and pituitary adenoma as well as improved reconstructive techniques in reducing CSF leaks. Evidence-based recommendations are limited in other pathologies and these significant knowledge gaps call upon the skull-base community to embrace these opportunities and collaboratively address these shortcomings.

Sections du résumé

BACKGROUND
Endoscopic skull-base surgery (ESBS) is employed in the management of diverse skull-base pathologies. Paralleling the increased utilization of ESBS, the literature in this field has expanded rapidly. However, the rarity of these diseases, the inherent challenges of surgical studies, and the continued learning curve in ESBS have resulted in significant variability in the quality of the literature. To consolidate and critically appraise the available literature, experts in skull-base surgery have produced the International Consensus Statement on Endoscopic Skull-Base Surgery (ICAR:ESBS).
METHODS
Using previously described methodology, topics spanning the breadth of ESBS were identified and assigned a literature review, evidence-based review or evidence-based review with recommendations format. Subsequently, each topic was written and then reviewed by skull-base surgeons in both neurosurgery and otolaryngology. Following this iterative review process, the ICAR:ESBS document was synthesized and reviewed by all authors for consensus.
RESULTS
The ICAR:ESBS document addresses the role of ESBS in primary cerebrospinal fluid (CSF) rhinorrhea, intradural tumors, benign skull-base and orbital pathology, sinonasal malignancies, and clival lesions. Additionally, specific challenges in ESBS including endoscopic reconstruction and complication management were evaluated.
CONCLUSION
A critical review of the literature in ESBS demonstrates at least the equivalency of ESBS with alternative approaches in pathologies such as CSF rhinorrhea and pituitary adenoma as well as improved reconstructive techniques in reducing CSF leaks. Evidence-based recommendations are limited in other pathologies and these significant knowledge gaps call upon the skull-base community to embrace these opportunities and collaboratively address these shortcomings.

Identifiants

pubmed: 31329374
doi: 10.1002/alr.22326
doi:

Types de publication

Consensus Development Conference Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S145-S365

Informations de copyright

© 2019 ARS-AAOA, LLC.

Auteurs

Eric W Wang (EW)

University of Pittsburgh, Pittsburgh, PA.

Adam M Zanation (AM)

University of North Carolina, Chapel Hill, NC.

Paul A Gardner (PA)

University of Pittsburgh, Pittsburgh, PA.

Theodore H Schwartz (TH)

Weill Cornell, New York, NY.

Nithin D Adappa (ND)

University of Pennsylvania, Philadelphia, PA.

Martin Bettag (M)

Hospital of Barmherzigen Brueder, Wien, Germany.

Benjamin S Bleier (BS)

Harvard University, Boston, MA.

Paolo Cappabianca (P)

University of Naples, Naples, Italy.

Ricardo L Carrau (RL)

Ohio State University, Columbus, OH.

Roy R Casiano (RR)

University of Miami, Miami, FL.

Luigi M Cavallo (LM)

University of Naples, Naples, Italy.

Charles S Ebert (CS)

University of North Carolina, Chapel Hill, NC.

Ivan H El-Sayed (IH)

University of California San Francisco, San Francisco, CA.

James J Evans (JJ)

Jefferson University, Philadelphia, PA.

Juan C Fernandez-Miranda (JC)

Stanford University, Stanford, CA.

Adam J Folbe (AJ)

Michigan Sinus and Skull Base Institute, Royal Oak, MI.

Sebastien Froelich (S)

Lariboisiere University, Paris, France.

Fred Gentili (F)

University of Toronto, Toronto, Canada.

Richard J Harvey (RJ)

University of Toronto, Toronto, Canada.
University of New South Wales, Sydney, Australia.

Peter H Hwang (PH)

Stanford University, Stanford, CA.

John A Jane (JA)

University of Virginia, Charlottesville, VA.

Daniel F Kelly (DF)

Pacific Neuroscience Institute, Santa Monica, CA.

David Kennedy (D)

University of Pennsylvania, Philadelphia, PA.

Engelbert Knosp (E)

Medical University of Vienna, Vienna, Austria.

Devyani Lal (D)

Mayo Clinic, Scottsdale, AZ.

John Y K Lee (JYK)

University of Pennsylvania, Philadelphia, PA.

James K Liu (JK)

Rutgers University, Newark, NJ.

Valerie J Lund (VJ)

University College London, London, United Kingdom.

James N Palmer (JN)

University of Pennsylvania, Philadelphia, PA.

Daniel M Prevedello (DM)

Ohio State University, Columbus, OH.

Rodney J Schlosser (RJ)

Medical University of South Carolina, Charleston, SC.

Raj Sindwani (R)

Cleveland Clinic, Cleveland, OH.

C Arturo Solares (CA)

Emory University, Atlanta, GA.

Abtin Tabaee (A)

Weill Cornell, New York, NY.

Charles Teo (C)

Prince of Wales Hospital, Randwick, Australia.

Parthasarathy D Thirumala (PD)

University of Pittsburgh, Pittsburgh, PA.

Brian D Thorp (BD)

University of North Carolina, Chapel Hill, NC.

Eduardo de Arnaldo Silva Vellutini (E)

University of Sao Paulo, Sao Paulo, Brazil.

Ian Witterick (I)

University of Toronto, Toronto, Canada.

Bradford A Woodworth (BA)

University of Alabama Birmingham, Birmingham, AL.

Peter-John Wormald (PJ)

Adelaide and Flinders Universities, Adelaide, Australia.

Carl H Snyderman (CH)

University of Pittsburgh, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH